Zinc supplementation (commonly used in Wilson disease maintenance therapy) induces intestinal metallothionein, which sequesters copper in enterocytes and reduces absorption [10]
Human safety data remains limited, and patients should avoid ordering research peptides online or guessing dosage without medical supervision
Li Y, Zhang C, Cheng H, Lv L, Zhu X, Ma M, et al
Full citations are listed under the Scientific References tab
For example, with reference to the clinical ocular trials mentioned in Sosne and Kleinman, the researchers noted that no long-term safety studies have been done with TI34 treatment in the eye for more than a month
TB-500 Both peptides continue to be subjects of active investigation